These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33880030)

  • 1. Association of Rheumatoid Arthritis with Diabetic Comorbidity: Correlating Accelerated Insulin Resistance to Inflammatory Responses in Patients.
    Verma AK; Bhatt D; Goyal Y; Dev K; Beg MMA; Alsahli MA; Rahmani AH
    J Multidiscip Healthc; 2021; 14():809-820. PubMed ID: 33880030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis, insulin resistance, and diabetes.
    Nicolau J; Lequerré T; Bacquet H; Vittecoq O
    Joint Bone Spine; 2017 Jul; 84(4):411-416. PubMed ID: 27777170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Systemic Inflammation on the Function of Insulin and Glucose Metabolism in Rheumatoid Arthritis.
    Herlitz-Cifuentes HS; Garces PC; Fernandez LI; Guzman-Gutierrez EA
    Curr Diabetes Rev; 2015; 12(2):156-62. PubMed ID: 26033386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
    Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
    J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
    Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
    JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
    Danve AS; Kulkarni S
    Am J Ther; 2017 May; 24(3):e347-e350. PubMed ID: 26103543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration.
    Guin A; Sinhamahapatra P; Misra S; Choudhury Mazumder SR; Chatterjee S; Ghosh A
    Biomed J; 2019 Dec; 42(6):394-402. PubMed ID: 31948603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis.
    Cheon YH; Lee SG; Kim M; Kim HO; Sun Suh Y; Park KS; Kim RB; Yang HS; Kim JM; Son CN; Kyoung Park E; Kim SH; Lee SI
    Brain Behav Immun; 2018 Oct; 73():274-281. PubMed ID: 29787856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated Atherosclerosis in Rheumatoid Arthritis: Mechanisms and Treatment.
    Reiss AB; Silverman A; Khalfan M; Vernice NA; Kasselman LJ; Carsons SE; De Leon J
    Curr Pharm Des; 2019; 25(9):969-986. PubMed ID: 31208307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease.
    Wasko MC; Kay J; Hsia EC; Rahman MU
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):512-21. PubMed ID: 21452264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Llorca J
    Ann N Y Acad Sci; 2010 Apr; 1193():153-9. PubMed ID: 20398022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
    Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
    Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis.
    Gaffo A; Saag KG; Curtis JR
    Am J Health Syst Pharm; 2006 Dec; 63(24):2451-65. PubMed ID: 17158693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation and low-dose glucocorticoid effects on glucose metabolism in premenopausal females with rheumatoid arthritis free of conventional metabolic risk factors.
    Penesová A; Rádiková Z; Vlček M; Kerlik J; Lukáč J; Rovenský J; Imrich R
    Physiol Res; 2013; 62(1):75-83. PubMed ID: 23173679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies toward rheumatoid arthritis therapy; the old and the new.
    Abbasi M; Mousavi MJ; Jamalzehi S; Alimohammadi R; Bezvan MH; Mohammadi H; Aslani S
    J Cell Physiol; 2019 Jul; 234(7):10018-10031. PubMed ID: 30536757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients.
    Castillo-Hernandez J; Maldonado-Cervantes MI; Reyes JP; Patiño-Marin N; Maldonado-Cervantes E; Solorzano-Rodriguez C; de la Cruz Mendoza E; Alvarado-Sanchez B
    Rev Bras Reumatol Engl Ed; 2017; 57(4):320-329. PubMed ID: 28743359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues.
    Arias de la Rosa I; Escudero-Contreras A; Rodríguez-Cuenca S; Ruiz-Ponce M; Jiménez-Gómez Y; Ruiz-Limón P; Pérez-Sánchez C; Ábalos-Aguilera MC; Cecchi I; Ortega R; Calvo J; Guzmán-Ruiz R; Malagón MM; Collantes-Estevez E; Vidal-Puig A; López-Pedrera C; Barbarroja N
    J Intern Med; 2018 Jul; 284(1):61-77. PubMed ID: 29532531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    Wang CR; Tsai HW
    World J Diabetes; 2021 Mar; 12(3):238-260. PubMed ID: 33758645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence?
    Cutolo M
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S26-31. PubMed ID: 14989426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.